HB 2008
In CommitteeHouse
Personal hygiene products
Concerning chemicals in certain personal hygiene products.
This status may be delayed. See Action History below for the latest updates.
How does a bill become law?
- Introduced: The bill is filed and assigned a number.
- Committee: A subject-matter committee holds hearings, takes public testimony, and decides whether to advance the bill.
- Floor Vote: The full chamber (House or Senate) debates and votes on the bill.
- Opposite Chamber: The bill repeats the committee and floor vote process in the other chamber.
- Governor: The Governor reviews the bill and decides whether to sign or veto it.
- Signed: The bill has been signed into law.
AI Analysis
This bill requires Washington’s Department of Ecology to test commonly used hygiene products—like diapers, incontinence products, and menstrual items—for potentially harmful chemicals. The goal is to identify unsafe substances and share findings with lawmakers by the end of 2025.
- Requires the Department of Ecology to test disposable and reusable diapers and incontinence products for harmful chemicals.
- Requires testing of menstrual products and related items (e.g., pads, tampons, menstrual cups) regulated by the U.S. Food and Drug Administration.
- Must consult with the Department of Health and community and social justice organizations during testing planning and implementation.
- Must deliver a technical report to the state legislature by December 31, 2025, summarizing findings on chemical presence and potential health risks.
Who is affected
- General public (especially people who menstruate and caregivers of infants/toddlers) — Consumers who use these products may be exposed to harmful chemicals; the bill aims to identify risks so safer options can be chosen or regulated.
- Product manufacturers and retailers — Manufacturers and sellers of the listed products may need to reformulate products or provide more ingredient transparency if harmful chemicals are found.
- Washington State Department of Ecology — Will use scientific testing and data analysis to assess chemical safety and inform lawmakers and the public.
- Washington State Department of Health — Will provide health expertise on potential risks of detected chemicals and advise on public health implications.
Pro/Con Analysis
Stronger case for benefits
Potential Benefits (4)
The bill directly protects public health by identifying potentially harmful chemicals (e.g., dioxins, phthalates, synthetic fragrances) in intimate hygiene products—products used by infants, people with incontinence, and menstruating individuals—many of whom are vulnerable populations with limited product choice.
HealthcarePeopleRef: Sec. 1(1)(a), Sec. 1(1)(b), Sec. 1(2)By requiring transparency and public reporting of chemical content, the bill empowers consumer autonomy and informed consent, especially for historically marginalized groups (e.g., low-income people, people of color, disabled individuals) who are disproportionately affected by toxic product exposure and have had less access to safety data.
Rights & LibertiesPeopleRef: Sec. 1(1), Sec. 1(2)Identifying and publicly reporting hazardous chemicals in hygiene products can prevent acute and chronic health harms—such as skin irritation, endocrine disruption, and reproductive toxicity—particularly for people with compromised immune systems or chronic conditions.
Public SafetyPeopleRef: Sec. 1(1), Sec. 1(2)Testing may reveal persistent or bioaccumulative chemicals (e.g., PFAS, heavy metals) in disposable hygiene products, which contribute to environmental contamination when discarded—leading to future regulatory action that could reduce ecosystem harm.
EnvironmentPeopleRef: Sec. 1(1), Sec. 1(2)
Potential Concerns (3)
The bill may increase out-of-pocket costs for consumers if manufacturers reformulate products to avoid regulated chemicals, potentially raising prices for diapers, incontinence, and menstrual products—especially for low-income households and people on public assistance who rely on these items.
HealthcarePeopleRef: Sec. 1(1)(a), Sec. 1(1)(b)Small manufacturers and domestic producers (including those outside Washington) may face compliance costs—e.g., reformulation, third-party testing, labeling changes—if harmful chemicals are identified, potentially reducing market share or forcing exit from the market if they lack resources to adapt.
Business & EmploymentPeopleRef: Sec. 1(1)(a), Sec. 1(1)(b)The bill relies on existing Department of Ecology staff and resources, meaning no new funding is allocated—this could strain existing environmental monitoring programs if testing demands exceed current capacity, potentially delaying other regulatory work.
Local GovernmentRef: Fiscal Impact section
Who Is Most Affected
People who menstruate, caregivers of infants/toddlers, and individuals using incontinence products—especially low-income, elderly, or disabled individuals—will benefit from increased product safety and transparency, reducing exposure to endocrine-disrupting or carcinogenic chemicals.
Large national and multinational manufacturers (e.g., Procter & Gamble, Kimberly-Clark) are best positioned to absorb reformulation costs and may gain competitive advantage through 'clean' branding; small domestic producers may struggle with compliance costs and face market exit.
The Department of Ecology gains authority and scientific mandate to lead chemical safety assessments in a high-visibility public health area, but must reallocate existing staff time—potentially diverting resources from other regulatory priorities.
The Department of Health gains a formal advisory role in chemical risk assessment, strengthening its public health infrastructure—but its involvement is consultative, not decision-making, limiting direct influence over outcomes.
Advocacy groups for reproductive justice, disability rights, and environmental justice will gain leverage to push for future regulations based on the report’s findings—especially if harmful chemicals are confirmed in widely used products.